Joann Evangelista is a distinguished pharmaceutical leader, renowned for her expertise in drug safety, quality assurance, and operational innovation. In her current role in Quality Assurance, she leads the development of country-level quality strategies to ensure confidence in the Quality Management System (QMS) across global affiliates. Leveraging Quality by Design (QbD) and Critical-to-Quality (CtQ) principles, Joann enables risk-based, evidence-driven assurance that strengthens compliance while accelerating business outcomes.
She has transformed traditional operations into AI-driven workflows, navigating complex regulatory environments while maintaining high-quality outcomes. Joann’s leadership in audits, inspection readiness, and compliance programs—paired with her ability to integrate advanced technologies—has driven substantial cost savings, improved inspection confidence, and increased operational efficiency. Her work positions quality not as a control function, but as a strategic enabler of speed, scalability, and sustainable growth.
Joann’s innovative approach has transformed high-volume, high-budget programs through business optimization and AI-driven interventions. Her expertise in evolving multifaceted operating models ensures continuous improvement, cost reduction, and enterprise-wide efficiency. By championing AI and automation across the value chain, she helps Genentech scale effectively as the pipeline grows in complexity and volume.
With a customer-centric, enterprise-wide mindset, Joann bridges quality, operations, and innovation—ensuring that governance frameworks not only meet regulatory expectations but also enable faster, smarter decision-making. Her leadership reflects a forward-looking vision for quality in a digital era, where assurance, innovation, and business performance are deeply interconnected.